otake shigeki 大竹茂樹

… Alternative Names

OHTAKE SHIGEKI 大竹茂樹

OHTAKE Shigeki 大竹茂樹

Less

Researcher Number	00160523
Other IDs
Affiliation (Current)	2025: 金沢大学, その他部局等, その他
Affiliation (based on the past Project Information) *help	2017 – 2018: 金沢大学, その他部局等, その他 2016: 金沢大学, 国際基幹教育院, 教授 1999 – 2003: 金沢大学, 医学部, 教授
Review Section/Research Field	Principal Investigator Laboratory medicine / Hematology
Keywords	Principal Investigator PCR / CDR3 / Immunoglobulin gene / 免疫グロブリン遺伝子 / 急性骨髄性白血病 / 白血病 / 癌 / 疫学的検討 / 染色体核型 / 治療関連骨髄性腫瘍（t-MN） … More / CMMoL / MDS / AML / キメラ遺伝子解析 / 染色体異常 / 骨髄異形成症候群 / 治療関連骨髄性腫瘍 / NHL / Plasma DNA / 非ホジキンリンパ腫 / 非ホジキンリン / 血漿中核酸 / Acute Myeloid Leukemia / 表面抗原 / 免疫グロブリ遺伝子 Less

Epidemiological and molecular biological study of therapy-related myeloid neoplasmsPrincipal Investigator
- Principal Investigator
  
  OHTAKE SHIGEKI
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Kanazawa University
Establishment of tumor maker test using tumor-derived nucleic acids in plasmaPrincipal Investigator
- Principal Investigator
  
  OHTAKE Shigeki
- Project Period (FY)
  2002 – 2003
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Laboratory medicine
- Research Institution
  KANAZAWA UNIVERSITY
Clinical significance of lineage crossover in leukernic cellsPrincipal Investigator
- Principal Investigator
  
  OHTAKE Shigeki
- Project Period (FY)
  1999 – 2001
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Laboratory medicine
- Research Institution
  Kanazawa University

All 2019 2018 2017 Other

All Journal Article Presentation Other

[Journal Article] Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study.2019
- Author(s)
  Takeshita A, Asou N, Atsuta Y, Sakura T, Ueda Y, Sawa M, Dobashi N, Taniguchi Y, Suzuki R, Nakagawa M, Tamaki S, Hagihara M, Fujimaki K, Furumaki H, Obata Y, Fujita H, Yanada M, Maeda Y, Usui N, Kobayashi Y, Kiyoi H, Ohtake S, Matsumura I, Naoe T, Miyazaki Y
- Journal Title
  
  Leukemia
  
  Volume: 33 Issue: 2 Pages: 358-370
- DOI
  10.1038/s41375-018-0233-7
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09921, KAKENHI-PROJECT-17H04209, KAKENHI-PROJECT-16K08933, KAKENHI-PROJECT-16K09843, KAKENHI-PROJECT-18K08375, KAKENHI-PROJECT-19K07935
[Journal Article] Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study.2019
- Author(s)
  Kawashima N, Akashi A, Nagata Y, Kihara R, Ishikawa Y, Asou N, Ohtake S, Miyawaki S, Sakura T, Ozawa Y, Usui N, Kanamori H, Ito Y, Imai K, Suehiro Y, Kitamura K, Sakaida E, Takeshita A, Suzushima H, Naoe T, Matsumura I, Miyazaki Y, Ogawa S, Kiyoi H
- Journal Title
  
  Ann Hematol
  
  Volume: 98 Issue: 1 Pages: 83-91
- DOI
  10.1007/s00277-018-3492-5
- NAID
  120006623799
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09921, KAKENHI-PROJECT-17H04209, KAKENHI-PROJECT-16K08933, KAKENHI-PROJECT-16K09843, KAKENHI-PROJECT-19K07935
[Journal Article] Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study2018
- Author(s)
  Harada Y、Nagata Y、Kihara R、Ishikawa Y、Asou N、Ohtake S、Miyawaki S、Sakura T、Ozawa Y、Usui N、Kanamori H、Ito Y、Imai K、Suehiro Y、Kobayashi S、Kitamura K、Sakaida E、Onizuka M、Takeshita A、Ishida F、Suzushima H、Ishizawa K、Naoe T、Matsumura I、Miyazaki Y、Ogawa S、Kiyoi H
- Journal Title
  
  Leukemia Research
  
  Volume: 66 Pages: 20-27
- DOI
  10.1016/j.leukres.2018.01.008
- NAID
  120006473597
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K09843, KAKENHI-PROJECT-17K09921, KAKENHI-PROJECT-17H04209, KAKENHI-PROJECT-15K08609, KAKENHI-PROJECT-18K08375
[Journal Article] Distinct gene alterations with a high percentage of myeloperoxidase-positive leukemic blasts in de novo acute myeloid leukemia2018
- Author(s)
  Kamijo Rena、Itonaga Hidehiro、Kihara Rika、Nagata Yasunobu、Hata Tomoko、Asou Norio、Ohtake Shigeki、Shiraishi Yuichi、Chiba Kenichi、Tanaka Hiroko、Miyano Satoru、Ogawa Seishi、Naoe Tomoki、Kiyoi Hitoshi、Miyazaki Yasushi
- Journal Title
  
  Leukemia Research
  
  Volume: 65 Pages: 34-41
- DOI
  10.1016/j.leukres.2017.12.006
- NAID
  120006988058
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09843, KAKENHI-PROJECT-17K09921, KAKENHI-PROJECT-17H04209, KAKENHI-PROJECT-17K16189, KAKENHI-PLANNED-15H05909, KAKENHI-PROJECT-26221308
[Journal Article] Underweight status at diagnosis is associated with poorer outcomes in adult patients with acute myeloid leukemia: a retrospective study of JALSG AML 2012017
- Author(s)
  Harada Kaito、Doki Noriko、Hagino Takeshi、Miyawaki Shuichi、Ohtake Shigeki、Kiyoi Hitoshi、Miyazaki Yasushi、Fujita Hiroyuki、Usui Noriko、Okumura Hirokazu、Miyamura Koichi、Nakaseko Chiaki、Fujieda Atsushi、Nagai Tadashi、Yamane Takahisa、Sakamaki Hisashi、Ohnishi Kazunori、Naoe Tomoki、Ohno Ryuzo、Ohashi Kazuteru
- Journal Title
  
  Annals of Hematology
  
  Volume: 97 Issue: 1 Pages: 73-81
- DOI
  10.1007/s00277-017-3156-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K09843, KAKENHI-PROJECT-17K09921
[Journal Article] Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia2017
- Author(s)
  Kuwatsuka Y、Asou N、Ohtake S、Miyawaki S、Miyazaki Y、Sakura T、Ozawa Y、Usui N、Kanamori H、Ito Y、Imai K、Suehiro Y、Kobayashi S、Kitamura K、Sakaida E、Ogawa S、Naoe T、Hayashi Y、Horibe K、Manabe A、Mizutani S、Adachi S、Kiyoi H et al.
- Journal Title
  
  International Journal of Hematology
  
  Volume: 107 Issue: 2 Pages: 201-210
- DOI
  10.1007/s12185-017-2340-z
- NAID
  120006473552
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K09843, KAKENHI-PROJECT-17K08911, KAKENHI-PROJECT-17K09921, KAKENHI-PROJECT-17K10130, KAKENHI-PROJECT-15K08654, KAKENHI-PROJECT-17H04110
[Presentation] Clinical significance of ASXL2 and ZBTB7A mutations and AML1-ETO9a expression in AML with t(8;21): the JALSG AML201 study.2018
- Author(s)
  Kawashima N, Ishikawa Y, Kiyoi H, Atsuta Y, Ohtake S, Asou N, Miyazaki Y, et al.
- Organizer
  International Society of Hematology. Annual Meeting.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09843
[Presentation] Prospective Evaluation of Prognostic Relevance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: Results from the JALSG CBF-AML209-KIT Study.2018
- Author(s)
  Kawashima N, Ishikawa Y, Atsuta Y, Sugiura I, Sawa M, Dobashi N, Yokoyama H, Doki N, Tomita A, Kiguchi T, Koh S, Kanamori H, Iriyama N, Kohno A, Moriuchi Y, Asada N, Hirano D, Togitani K, Sakura T, Hagihara M, Tomikawa T, Yokoyama Y, Asou N, Ohtake S, Matsumura I, Miyazaki Y, Naoe T and Kiyoi H
- Organizer
  60th American Society of Hematology Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09843
[Presentation] Tamibarotene As Maintenance Therapy for Acute Promyelocytic Leukemia Improved Long Term Relapse-Free Survival: 7-Year Results from a Randomized Controlled Trial, JALSG-APL204.2017
- Author(s)
  Takeshita A, Asou N, Yanada M, Sakura T, Ueda Y, Sawa M, Dobashi N, Onizuka M, Taniguchi Y, Nakagawa M, Tamaki S, Hagihara M, Fujimaki K, Furumaki H, Fujita H, Usui N, Kobayashi Y, Kiyoi H, Ohtake S, Atsuta Y, Matsumura I, Naoe T and Miyazaki Y
- Organizer
  第59回米国血液学会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09843
[]

1. OKUMURA Hirokazu (30242548)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
2. 片桐孝和 (60621159)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. MIYAZAKI yasushi

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
4. KIYOI hitoshi

# of Collaborated Projects: 1 results

# of Collaborated Products: 9 results

otake shigeki 大竹 茂樹

OHTAKE SHIGEKI 大竹 茂樹

OHTAKE Shigeki 大竹 茂樹

Research Projects

Research Products

Co-Researchers

Epidemiological and molecular biological study of therapy-related myeloid neoplasmsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Establishment of tumor maker test using tumor-derived nucleic acids in plasmaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Clinical significance of lineage crossover in leukernic cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study.2019

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study2018

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Distinct gene alterations with a high percentage of myeloperoxidase-positive leukemic blasts in de novo acute myeloid leukemia2018

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Underweight status at diagnosis is associated with poorer outcomes in adult patients with acute myeloid leukemia: a retrospective study of JALSG AML 2012017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia2017

Author(s)

Journal Title

DOI

NAID

Data Source

[Presentation] Clinical significance of ASXL2 and ZBTB7A mutations and AML1-ETO9a expression in AML with t(8;21): the JALSG AML201 study.2018

Author(s)

Organizer

Data Source

[Presentation] Prospective Evaluation of Prognostic Relevance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: Results from the JALSG CBF-AML209-KIT Study.2018

Author(s)

Organizer

Data Source

[Presentation] Tamibarotene As Maintenance Therapy for Acute Promyelocytic Leukemia Improved Long Term Relapse-Free Survival: 7-Year Results from a Randomized Controlled Trial, JALSG-APL204.2017

Author(s)

Organizer

Data Source

[]

otake shigeki 大竹茂樹

OHTAKE SHIGEKI 大竹茂樹

OHTAKE Shigeki 大竹茂樹